Ellington Management Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-9,200
Closed -$827K 205
2020
Q1
$827K Buy
9,200
+6,600
+254% +$855K 0.19% 144
2019
Q4
$384K Sell
2,600
-1,923
-43% -$258K 0.08% 237
2019
Q3
$545K Buy
4,523
+2,423
+115% +$313K 0.1% 213
2019
Q2
$284K Buy
+2,100
New +$266K 0.05% 372
2017
Q3
Sell
-7,100
Closed -$619K 714
2017
Q2
$619K Sell
7,100
-100
-1% -$8.46K 0.09% 184
2017
Q1
$641K Buy
+7,200
New +$600K 0.02% 238
2016
Q4
Sell
-6,400
Closed -$484K 644
2016
Q3
$484K Buy
+6,400
New +$490K 0.13% 290
2016
Q2
Sell
-3,000
Closed -$234K 347
2016
Q1
$234K Buy
+3,000
New +$209K 0.1% 315
2015
Q3
Sell
-7,600
Closed -$689K 776
2015
Q2
$689K Buy
+7,600
New +$609K 0.17% 163
2015
Q1
Sell
-4,500
Closed -$330K 737
2014
Q4
$330K Buy
+4,500
New +$316K 0.11% 310
2014
Q3
Sell
-4,100
Closed -$231K 359
2014
Q2
$231K Sell
4,100
-8,300
-67% -$438K 0.11% 309
2014
Q1
$651K Buy
+12,400
New +$617K 0.19% 148
2013
Q3
Sell
-48,200
Closed -$1.74M 851
2013
Q2
$1.74M Buy
+48,200
New +$1.86M 0.33% 46

Other funds holding HCA

Ellington Management Group's HCA Position: Q2 2020 in Review

Ellington Management Group sold out of HCA Healthcare (HCA) in Q2 2020, closing a stake of 9,200 shares — an estimated $827K sold.

Ellington Management Group first reported a position in HCA in Q2 2013 and held it in 13 quarters. The position peaked at $1.74M in Q2 2013. 686 funds tracked by Wall St. Rank hold HCA as of Q2 2020.

  • Ellington Management Group reported no remaining HCA Healthcare position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 9,200 HCA Healthcare shares in Q2 2020, an estimated $827K.
  • Ellington Management Group first reported a position in HCA Healthcare in Q2 2013 and held it in 13 quarters.
  • Ellington Management Group's HCA Healthcare position peaked at $1.74M in Q2 2013.
  • 686 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.